SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-088395
Filing Date
2024-08-12
Accepted
2024-08-12 16:42:26
Documents
17
Period of Report
2024-08-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2421034d1_8k.htm   iXBRL 8-K 42046
2 EXHIBIT 10.1 tm2421034d1_ex10-1.htm EX-10.1 19989
3 EXHIBIT 99.1 tm2421034d1_ex99-1.htm EX-99.1 10007
8 GRAPHIC tm2421034d1_ex99-1img001.jpg GRAPHIC 2132
  Complete submission text file 0001104659-24-088395.txt   309556

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zura-20240812.xsd EX-101.SCH 3257
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zura-20240812_def.xml EX-101.DEF 26908
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20240812_lab.xml EX-101.LAB 36515
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20240812_pre.xml EX-101.PRE 25532
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2421034d1_8k_htm.xml XML 5565
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 241197484
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)